Mirabella Financial Services’s Jazz Pharmaceuticals JAZZ Stock Holding History

Mirabella Financial Services’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-1,557	Closed	-$294K	–	938
2026 Q1	$294K	Sell	1,557 -186	-11%	-$32.5K	0.03%	511
2025 Q4	$296K	Sell	1,743 -105	-6%	-$16.1K	0.03%	462
2025 Q3	$244K	Buy	+1,848	New	+$222K	0.02%	207
2023 Q2	–	Sell	-3,360	Closed	-$492K	–	573
2023 Q1	$492K	Buy	+3,360	New	+$497K	0.07%	218
2022 Q2	–	Sell	-13,797	Closed	-$2.15M	–	589
2022 Q1	$2.15M	Buy	+13,797	New	+$2M	0.24%	80

Other funds holding JAZZ

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Mirabella Financial Services's JAZZ Position: Q2 2026 in Review

Mirabella Financial Services sold out of Jazz Pharmaceuticals (JAZZ) in Q2 2026, closing a stake of 1,557 shares — an estimated $294K sold.

Mirabella Financial Services first reported a position in JAZZ in Q1 2022 and held it in 5 quarters. The position peaked at $2.15M in Q1 2022. 647 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

Mirabella Financial Services reported no remaining Jazz Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Mirabella Financial Services sold 1,557 Jazz Pharmaceuticals shares in Q2 2026, an estimated $294K.
Mirabella Financial Services first reported a position in Jazz Pharmaceuticals in Q1 2022 and held it in 5 quarters.
Mirabella Financial Services's Jazz Pharmaceuticals position peaked at $2.15M in Q1 2022.
647 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Mirabella Financial Services's 13F filing for Q2 2026, filed 31 Jul 2026.